Podcasts about transplants

A Christchurch teenager is being forced to put his life on hold as he awaits a life-saving heart transplant. Shade Beardsall has hyper-trophic cardio-myopathy which causes the heart to grow thicker than normal. It's a condition that has already had tragic consequences for Shade's family. It comes as the number of organs being donated falls behind the number of people waiting for a transplant, both here and abroad. Adam Burns reports.

Amy Honeycutt received a liver transplant in 2011 and became a donor family member in 2016. She currently works as an RN Allocation Coordinator in sunny San Diego and is school to become a Psychiatric Mental Health Nurse Practitioner. Other than work, school, and numerous professional and advocacy endeavors, Amy enjoys traveling with her boyfriend, being a dog mom, all the sports, and being an Aunt.

Today on the Naked Scientists: a pig lung is transplanted into a man in China, but what was the outcome? Also, scientists have a theory for the origins of Dark Energy - and it makes sense that a black hole might be the source! And, why the dawn chorus is starting earlier and finishing later these days: what's getting into wildlife? Like this podcast? Please help us by supporting the Naked Scientists

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: CRISPR modified cell transplant for type 1, risk of T1D if parent has a different type of diabetes, Metformin and the brain, oral GLP-1, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A 42-year-old man who has lived most of his life with type 1 diabetes has become the first human to receive a transplant of genetically modified insulin-producing cells. This marks the first pancreatic cell transplant in a human to sidestep the need for immunosuppressant drugs. “This is the most exciting moment of my scientific career,” says cell biologist Per-Ola Carlsson of Uppsala University in Sweden, who helped develop the procedure. The new treatment, he says, “opens the future possibility of treating not only diabetes but other autoimmune diseases.” This procedure uses the gene editing technique, CRISPR, to discourage the auto immune attack on the donor cells. Before the transplant, the participant had no measurable naturally produced insulin and was receiving daily doses of the hormone. But within four to 12 weeks following the transplant, his levels rose slightly on their own after meals—showing that the new beta cells were releasing some insulin in response to glucose. even though the new study is promising, it involved just one participant and is therefore preliminary. And longer-term monitoring is needed to confirm the therapy's safety before it can be offered to more people. She also notes that the injected cells produced only 7 percent of the insulin needed for a person to be fully independent of additional medication. The researchers supplied the recipient with insulin doses to maintain healthy blood sugar levels. While Herold thinks it's still too early to consider this approach for a cure, “these options are now here to change the disease in ways that have never been possible before,” he says. “There's tremendous hope.” https://www.scientificamerican.com/article/type-1-diabetes-patients-insulin-production-restored-with-new-cell/ XX   This one is interesting… a recent study shows that children of mothers with gestational diabetes or fathers with type 2 diabetes have higher chances of developing type 1 diabetes than kids whose parents do not have any type of diabetes. Specifically, the study found that children whose mothers had gestational diabetes during pregnancy were 94% more likely to develop type 1 diabetes compared to children of mothers without diabetes. Similarly, having a father with type 2 diabetes was linked to a 77% higher risk. The study also suggests a possible link between maternal type 2 diabetes and type 1 diabetes in children, although more data are needed to confirm whether the risk is real.   "What is interesting is that type 1 diabetes is a disease of lack of the hormone insulin while gestational diabetes and type 2 diabetes stem mostly from the body's resistance to the hormone. What may be happening is that genes, environments and behaviors that create insulin resistance may also, in some cases, trigger the immune reactions that lead to type 1 diabetes," adds Dr. Dasgupta. A 2019 meta-analysis by researchers at Soochow University in China found that gestational diabetes was linked to a 66% higher risk of type 1 diabetes in children. This new study, which includes more than twice as many studies, offers a robust synthesis of current evidence and shows the risk is even greater than previously estimated. It is also the first meta-analysis to examine the link between paternal type 2 diabetes and type 1 diabetes in offspring. "Several mechanisms may be at play. Families often share lifestyle and eating habits, which can raise the likelihood that children will be affected. But beyond that, high blood sugar levels may also cause biological changes in parents that could increase their children's risk of developing type 1 diabetes," explains Laura Rendon, co-first author of the study, who completed an MSc in experimental medicine at The Institute and, as someone living with type 1 diabetes herself, finds deep personal meaning in conducting this research. For instance, the authors suggest that high blood sugar during pregnancy may stress the fetus's insulin-producing beta cells, reducing their number at birth or making them more vulnerable to damage later in life. It may also trigger epigenetic changes—modifications to proteins and molecules attached to DNA—that increase the risk. Likewise, high blood sugar in fathers with type 2 diabetes may cause epigenetic changes in their sperm, potentially influencing their child's risk of developing type 1 diabetes. https://medicalxpress.com/news/2025-08-diabetes-children-linked-parents.html XX Can a CGM help you lose weight? The company Signos is banking on it – the just got FDA approval for their system, which uses the over the counter Dexcom Stelo. The claim here is that the system will help track how food choices, activity, stress and sleep can all affect metabolism. Signos also works in partnership with the digital nutrition counseling startup Nourish. It currently offers a quarterly subscription plan, including six CGM sensors, for $139 per month. And they tell you don't take any medical actions based on the app's output without consulting a physician. https://www.fiercebiotech.com/medtech/fda-clears-signos-over-counter-cgm-powered-weight-loss-app XX Good news for T1D1, a free mobile app that helps people calculate insulin doses, track daily data, and share insights with healthcare providers. After being pulled off the market with similar apps a few years ago, it's now back and FDA approved. Drew Mendelow created the app after his diagnosis at age 13. He came on the show last year and I'll link his story up in the show notes. Diabetes Center Berne provided the initial funding to support the T1D1 efforts to redesign the app per FDA standards.  Comerge AG , the registered manufacturer, enlisted a team of software engineers, regulatory experts, and design professionals to ensure T1D1 was FDA-ready. Dexcom graciously conducted the Human Factors study to ensure safety and accuracy.  ​ ​T1D1 is now FDA-cleared as a Class II medical device and is the first over-the-counter insulin calculator cleared for individuals aged 2 and older. T1D1 is expected to be live in the AppStore and Google Play Store by October 2025. https://diabetes-connections.com/the-fda-took-down-this-teens-free-bolus-calculator-he-needs-your-help-to-bring-it-back/ XX Metformin has been the standard treatment for type 2 diabetes for more than six decades, yet scientists still do not fully understand how it works. A team from Baylor College of Medicine, working with international collaborators, has now identified an unexpected factor in its effectiveness: the brain. Their findings reveal a brain pathway involved in metformin's glucose-lowering action, pointing to new strategies for treating diabetes with greater precision. The study was published in Science Advances. The researchers concentrated on a small protein called Rap1, located in a region of the brain known as the ventromedial hypothalamus (VMH). They discovered that metformin's ability to lower blood sugar at clinically relevant doses depends on suppressing Rap1 activity in this brain area.   “This discovery changes how we think about metformin,” Fukuda said. “It's not just working in the liver or the gut, it's also acting in the brain. We found that while the liver and intestines need high concentrations of the drug to respond, the brain reacts to much lower levels.”     https://scitechdaily.com/after-60-years-scientists-uncover-hidden-brain-pathway-behind-diabetes-drug-metformin/   XX Looks like GLP-1 pills are moving ahead. Lilly says it's version helped overweight adults with type 2 lose 10% of their body weights and lower A1C. Just two weeks ago, we were talking about how the same drug in people without diabetes had less than the stellar expected results. Orforglipron is a small-molecule pill that is easier to manufacture and package than wildly popular injectable drugs for obesity, such as Lilly's Zepbound and Novo Nordisk's NOVOb.CO rival treatment Wegovy, which are peptide mimics of the appetite-controlling GLP-1 hormone. In the 72-week study of more than 1,600 overweight or obese adults with type 2 diabetes, those who received the 36-milligram highest dose of orforglipron on average shed 10.5% of their weight, or about 23 pounds (10.43 kg), versus 2.2% for those who received a placebo, achieving the main goal of the trial. Patients on the lowest 6 mg dose of the Lilly drug lost 5.5% of their weight. https://www.usatoday.com/story/news/health/2025/08/26/lilly-glp-1-pill-weight-loss/85830686007/ XX     An intervention that combined a low-calorie Mediterranean diet and exercise led to less diabetes incidence in older adults. Men had a greater diabetes risk reduction with the intervention than women. The study was based in Spain, and the diet may not be as easy to adhere to in the U.S. Among nearly 5,000 adults with metabolic syndrome and overweight or obesity in the PREDIMED-Plus trial, those who followed this intervention had a 31% lower risk for type 2 diabetes over 6 years relative to those who received only ad libitum Mediterranean diet advice (aHR 0.69, 95% CI 0.59-0.82). the Mediterranean diet focuses on high intake of plant-based foods, moderate consumption of fish, poultry, and dairy with optional red wine, and low intake of red meats, sweets, and sugar-sweetened beverages. Common foods featured in the diet include extra-virgin olive oil, fruits, vegetables, legumes, nuts, and whole grains. However, Sharon Herring, MD, MPH, and Gina Tripicchio, PhD, MSEd, both of Temple University in Philadelphia, pointed out that this study was conducted solely in Spain, and sticking to this type of diet may be more challenging in countries like the U.S.   "Participants in the study received extra-virgin olive oil to support adherence and retention; in the United States, prices of extra-virgin olive oil have nearly doubled since 2021 due to a combination of factors including climate change, rising production costs, supply chain disruptions, and now tariffs," they noted in an accompanying editorial. "[T]he large number of dietitian contacts during the study may prove difficult to scale broadly in the United States given challenges with health care access and reimbursement for prevention services."         https://www.medpagetoday.com/primarycare/diabetes/117151 XX A group of Canadian researchers has identified an unexpected way to lower blood sugar and protect the liver: by capturing a little-known fuel produced by gut bacteria before it enters the body and causes harm. The findings, published in Cell Metabolism, could open the door to new therapies to treat metabolic diseases like type 2 diabetes and fatty liver disease. Scientists from McMaster University, Université Laval, and the University of Ottawa discovered that a molecule generated by gut microbes can cross into the bloodstream, where it drives the liver to overproduce glucose and fat. By designing a method to trap this molecule in the gut before it reaches circulation, they achieved striking improvements in blood sugar regulation and fatty liver disease in obese mice. https://scitechdaily.com/scientists-discover-a-surprising-new-way-to-fight-diabetes/ XX Dexcom, which specializes in technology for glucose biosensing, will lay off 350 workers, with nearly 200 of them in San Diego, according to the San Diego Union Tribune. The bulk of the local jobs being lost are focused on Dexcom operations and manufacturing. The Dexcom development follows cutbacks to Verily, a life sciences company that is a subsidiary of Alphabet, Google's corporate parent. Verily's work included a project with Dexcom on wearable glucose sensors. CEO Stephen Gillett, in a memo obtained by the publication, said there will be “workforce reductions across Verily.” A representative for Verily confirmed to Business Insider that “we have made the difficult decision to discontinue manufacturing medical devices and will no longer be supporting them going forward.” https://timesofsandiego.com/business/2025/08/27/report-life-sciences-firm-dexcom-lay-off-200-san-diego-workers/ XX Front office changes at Insulet. Eric Benjamin, former chief product and customer experience officer, will take the role of chief operating officer, effective immediately. Manoj Raghunandanan Mu-NOHJ Rug-a-nun-da-nun to the position of chief growth officer, leading Insulet's new growth organization. The appointments are some of CEO Ashley McEvoy's first changes since she was hired in April. The appointments come after McEvoy outlined four priorities for Insulet on an August earnings call:   enhancing the company's commercial capabilities, building Insulet's brand and direct-to-consumer capabilities, driving growth outside of the U.S. and accelerating the pace of innovation. https://www.medtechdive.com/news/insulet-eric-benjamin-manoj-raghunandanan-appointments/758668/ XX   XX Want to highlight The Children's Diabetes Foundation in Colorado – they held a medal ceremony for patients of the Barbara Davis Center who've lived with Type 1 diabetes for 50 years or more. There were 87 medal recipients in the ceremony including Dana Davis, Executive Director of the Children's Diabetes Foundation and the daughter of the founders of the Barbara Davis Center. Davis shared: "When you got Type1 diabetes in the 70s, they thought you shouldn't have children. They thought you weren't going to live past 30 or 40. It was definitely very different," Davis said.   https://www.cbsnews.com/colorado/news/barbara-davis-center-celebrates-colorado-type-1-diabetes-patients-milestone/

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from August 23-29, 2025.

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:Direct and indirect effects of CMV infectionRisk factors for resistant/refractory CMVDefining resistant/refractory CMVPresenter:Camille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:http://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

The light at the end of the d tunnel. Dale watched Weekend at Bernie's. Chuck has it on dvd or blu-ray and now Dale wants it. I forget what else happened. ChaptersHog Tape Summer! (00:00:00)Banz week in news (00:05:56)Hog - The Amazing Transplant (00:29:15)Mail! (00:54:54)Next Episode! (00:59:41)LinksCheck out or Ko-fi at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://ko-fi.com/batandspider⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠DISCORD⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get your ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bat & Spider STICKERS here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Steve Barkett Rules t-shirts!!!⁠⁠⁠⁠⁠⁠Get a sweet Bat & Spider ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠t-shirt here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠! All sale proceeds go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Movement For Black Lives⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Technical Adviser: Slim of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠70mm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theme song composed and performed by Tobey Forsman of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Whipsong Music⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bat & Spider on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Chuck⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dale⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Letterboxd.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bat & Spider on Letterboxd⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bat & Spider Watchlist⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Send us an email: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠batandspiderpod@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Leave us a voice message: (315) 544-0966Artwork by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Charles Forsman⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠batandspider.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bat & Spider is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TAPEDECK⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ podcast, along with our friends at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠70mm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Letterboxd Show⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Escape Hatch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Will Run For...⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twin Vipers⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Movie Mixtape⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Yeti is Still Broken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Austin Danger Pod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lost Light⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. ★ Support this podcast ★

The morning show shares their opionions on John Cena recent hair transplant and how it has affected him. In addition they give their overall opionions on bald people and if they could go bald. 

REPLAY FROM APRIL 27, 2023The first episode of the Coffee With Podcast features Matthew Hankes, Heart Transplant Recipient. Matt is a pretty normal guy who experienced an extraordinary thing. He spent an hour talking about finding out he had a heart condition known as ARVC—Arrhythmogenic Right Ventricular Cardiomyopathy—at age 15, the lead-up to the transplant, and what it looks like from the other side. Matt asked that if anything be taken away from this podcast, it is the need for more donors on the transplant list.Sign up, make sure you're on the transplant donor list, or learn more about what that entails at ⁠https://donatelife.net/⁠.Other important links from the show:Matt Hankes fundraiser - ⁠https://donate.transplants.org/story/Matthankes⁠ (tax-deductible donations distributed directly for medical bills through the ⁠National Foundation for Transplants, Inc.⁠The United Network for Organ Sharing - ⁠https://unos.org/⁠Find the Coffee With Podcast here - Search for other Roast! West Coast podcasts like Coffee Smarter and Coffee People on your favorite podcast platforms, or find all the links on ⁠www.roastwestcoast.com⁠.People is presented by Roastar, Inc., the premier coffee packaging company utilizing digital printing. Roastar enables small-to-gigantic coffee businesses tell a big story. Learn more at ⁠https://bit.ly/4gIsHff⁠. Brands We've Partnered With:*Shop for Yeah, No...Yeah, our collaboration roast with Relative Coffee celebrating a Midwest turn of phrase. Buy Now: ⁠https://relativecoffeeco.com/products/yeah-no-yeah⁠ Shop for the Simply Good Brewer. We've used ours nearly 1000 times: ⁠https://partners.simplygoodcoffee.com/roast⁠Buy us a cup of coffee! ⁠https://roastwestcoast.substack.com/subscribe⁠Coffee People is one of the premier coffee and entrepreneurship podcasts, featuring interviews with professionals in the coffee industry and coffee education. Host Ryan Woldt interviews roastery founders, head roasters, coffee shop owners, scientists, artists, baristas, farmers, green coffee brokers, and more. This show is also supported by Marea Coffee , Cape Horn Green Coffee Importers, Sivitz Roasting Machines, Relative Coffee Company, Coffee Cycle Roasting, MAMU Coffee, and Hacea Coffee Source.Head to www.roastwestcoast.com for show recaps, coffee education, guest list and coffee news. Register to become an organ donor at: ⁠https://registerme.org/⁠.*Clicking these links to purchase will also support Roast! West Coast through their affiliate marketing programs.

Máiread O'Mahony reflects with PJ on how her brother's life-saving gift meant she became a champion athlete again Hosted on Acast. See acast.com/privacy for more information.

Pippa Hudson speaks to Carla Wilmans from the Wits Donald Gordon Medical Centre, a private academic teaching hospital which is home to the largest private-sector solid organ transplant programme in South Africa. August is National Organ Donor Awareness Month. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Headlines: – Welcome to Mo News + PSL Season Starts… Now (02:00) – Trump Wants to Send the National Guard to Chicago; Chicago Doesn't Want Them (05:40) – Trump Signs Executive Orders Aimed At Ending Cashless Bail in D.C. and Across The Nation (14:10) – President Trump Fires Federal Reserve Governor Lisa Cook (18:10) – Abrego Garcia Shielded From Deportation As Judge Questions Legal Process (21:00) – Trump Signs Executive Order Targeting American Flag Burning (24:40) – First Pig-To-Human Lung Transplant Announced By Chinese Scientists (27:20) – Keurig Dr Pepper to Acquire Peet's in $18 Billion Deal (30:00) – Redraw World Map ‘To Show Greatness of Africa', Demand Nations (34:00) – Netflix's ‘Kpop Demon Hunters' Leads With Estimated $18 Million Debut, ‘Weapons' Stays Strong With $15.6 Million (38:30) – On This Day In History (39:45) Thanks To Our Sponsors:  – ⁠LMNT⁠ - Free Sample Pack with any LMNT drink mix purchase –⁠ Industrious⁠ - Coworking office. 50% off day pass | Promo Code: MONEWS50 – Incogni - 60% off an annual plan| Promo Code: MONEWS – Leesa – 30% off mattress, plus extra $50 off | Promo Code: MONEWS – Factor Meals – 50% your first box plus free shipping | Promo Code: monews50off – Monarch Money - 50% off your first year | Promo Code: MONEWS

Kenny Wallace discusses his hair transplant and the time in 1988 that Rusty Wallace flipped and almost died at Bristol.#kennywallace #nascar #racingBrought to you by JEGS! Click here: http://jegs.ork2.net/rQ9Oy5Use Promo Code DEALS To Save Up To 50% OFF Sitewide! Shop Doorbusters, Stackable Savings & 1,000's of Deals at JEGS!JEGS has been in business since 1960.Racers selling to racers.Focusing on American Muscle – but also big product line of automotive tools, garage gear & other performance parts.JEGS is well established with racers of all kinds, including the NHRA, bracket racing, circle track & more!Free shipping on orders over $199.Unrivaled expertise from techs.

A stroke, a transplant, and a family's resilience — Brian & Brittany share how recovery goes far beyond the symptoms. The post Bryan & Brittany: Finding Strength in Recovery and Transplant appeared first on Recovery After Stroke.

Is August too soon to be heading back to school, Claire Cassidy on the everyday obstacles that can injure visually impaired people, drone testing, reporter Paul Byrne shares a fire safety warning, the Cork woman who won 3 golds and broke a world record at the Transplant games and we hear about the wellbeing and recovery college at IRD Duhallow Hosted on Acast. See acast.com/privacy for more information.

UAB's adult ECMO program, which offers advanced heart and lung support, continues to expand in both reach and capability. Keith Willie, M.D., medical director of the ECMO and Advanced Lung Diseases Program, discusses technology that improves patient mobility, new referral partnerships, and the multidisciplinary care model behind each case. Learn how ECMO is used as a bridge to recovery, transplant, or decision.  Learn more about Keith Wille, MD, MSPH 

Reporter, Gavin O'Callaghan interviews some of the twenty-nine athletes who competed in the World Transplant Games in Dresden, Germany.

We also learned that Booker "had one that didn't drop" as a kid AND that Alex wouldn't donate one if needed

Physician and public health advocate Judith Eguzoikpe discusses her article, "Hope is the lifeline: a deeper look into transplant care." She pulls back the curtain on the kidney transplant process, revealing that the true journey for patients with end-stage kidney disease is not just a single surgery but months or years of emotional and logistical challenges. Judith shares powerful patient stories that illustrate the fear, frustration, and uncertainty that define the waiting period. The conversation highlights the essential role of health care professionals as advocates who must provide not just information but presence and compassion. She also confronts the stark inequities in the system, where marginalized communities face greater barriers to care. The core message is a call for clinicians to look beyond lab values and recognize that building hope through advocacy and human connection is a critical part of the treatment itself. Careers by KevinMD is your gateway to health care success. We connect you with real-time, exclusive resources like job boards, news updates, and salary insights, all tailored for health care professionals. With expertise in uniting top talent and leading employers across the nation's largest health care hiring network, we're your partner in shaping health care's future. Fulfill your health care journey at KevinMD.com/careers. VISIT SPONSOR → https://kevinmd.com/careers Discovering disability insurance? Pattern understands your concerns. Over 20,000 doctors trust us for straightforward, affordable coverage. We handle everything from quotes to paperwork. Say goodbye to insurance stress – visit Pattern today at KevinMD.com/pattern. VISIT SPONSOR → https://kevinmd.com/pattern SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Lerche, Sabine www.deutschlandfunk.de, Sportgespräch

Lerche, Sabine www.deutschlandfunkkultur.de, Nachspiel

In this week's episode we'll learn about how by combining PET response with circulating tumor DNA, or  ctDNA, in newly treated patients with follicular lymphoma, investigators identify those patients likely to progress within 24 months of initial treatment, also known as POD24. After that: Immune hotspots in aplastic anemia. These newly identified hotspots potentially represent sites in the bone marrow where the active immune response takes place, driving the destruction of hematopoietic stem and progenitor cells. Finally, allogeneic transplantation for Hodgkin lymphoma in the checkpoint inhibitor era. In a large, retrospective study, patients with prior checkpoint inhibitor exposure had remarkable outcomes, particularly when post-transplant cyclophosphamide was used.Featured Articles: Combined PET and ctDNA response as predictors of POD24 for follicular lymphoma after first-line induction treatmentImaging Mass Cytometry Reveals the Order of Events in the Pathogenesis of Immune-Mediated Aplastic AnemiaOutcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Kenneth Liao, professor of surgery and chief of the Division of Cardiothoracic Transplantation and Circulatory Support at Baylor College of Medicine, about performing the world's first adult robotic heart surgery in the United States using a subxiphoid approach. Chapters 00:00 Intro 02:31 JANS 1, Endocarditis Guidelines 13:02 JANS 2, Hybrid vs Catheter 16:16 JANS 3, Full Sternotomy Trial 18:07 JANS 4, Buttressing the BA 19:05 JANS 5, Intraspinal Vasc Perf 20:15 Career Center 20:37 Video 1, Root Replace & Ann Reconstr 21:56 Video 2, Bi-Atrial Cann for BVAD 24:17 Video 3, Pediatric Device Implant 26:23 Dr. Liao Interview 49:07 Upcoming Events 49:39 Closing They discuss the details of the procedure, including its background, ischemic time, technique, and postoperative outcomes. Additionally, they explore the application of the subxiphoid approach for robotic heart transplants and robotic mitral valve repair vs traditional open-chest (sternotomy) repair. Dr. Liao shares insights into the training and practice required for this operation and discusses the advantages of using robotics in heart transplants. He also reflects on what he would do differently in future procedures.   Joel also highlights recent JANS articles on the surgical implications of the 2023 ESC endocarditis guidelines endorsed by EACTS, the two-year results from the randomized CEASE-AF trial on the durable effectiveness and safety of hybrid ablation vs catheter ablation, a randomized trial on superficial parasternal intercostal plane block and full sternotomy, a comparison of the short- and long-term outcomes in patients undergoing sleeve lobectomy with or without buttressing the bronchial anastomosis, and intraspinal vascular perfusion territories of the descending thoracic aorta.  In addition, Joel explores free-style root replacement and annular reconstruction for destructive aortic root endocarditis, bi-atrial cannulation for biventricular assist device in children, and a device implantation in a 26 kg child. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Surgical Implications of the 2023 ESC Endocarditis Guidelines Endorsed by EACTS: Bridging Guidelines and Practice   2.) Durable Effectiveness and Safety of Hybrid Ablation Versus Catheter Ablation: 2-year Results From the Randomized CEASE-AF Trial  3.) Superficial Parasternal Intercostal Plane Block and Full Sternotomy; A Randomized Trial  4.) Comparison of Short- and Long-Term Outcomes in Patients Undergoing Sleeve Lobectomy With or Without Buttressing the Bronchial Anastomosis  5.) Intraspinal Vascular Perfusion Territories of the Descending Thoracic Aorta  CTSNET Content Mentioned  1.) Free-Style Root Replacement and Annular Reconstruction for Destructive Aortic Root Endocarditis  2.) Bi-Atrial Cannulation for Biventricular Assist Device in Children  3.) Device Implantation in a 26 kg Child  Other Items Mentioned  1.) Guest Editor Series Webinar: Insights Into Pediatric Mechanical Circulatory Support  2.) Cardiac Surgical Arrest—An International Conversation Series    3.) Career Center   4.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

durée : 00:04:35 - Le Son d'Outre-mer - par : Marie Sorbier - Marie-Germaine Perigogne, une enfant dit "de la Creuse" se bat pour faire reconnaitre par l'État français ses responsabilités.

Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health.  The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company is developing a kit-based version of the test that can be run by hospitals rather than relying on centralized labs, to increase access to this diagnostic and improve transplant outcomes. Andrea explains, "We changed our name on June 17th from OncoCyte, as you had just referenced, to Insight Molecular Diagnostics Inc. We're now going by iMDx, and our mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes." "We actually have three pieces of IP, intellectual property, and we are initially commercializing in transplant. So we measure a biomarker called donor-derived cell-free DNA, don't get too hung up on it. That's a lot of words. It basically looks for fragments of DNA in the blood, which can indicate transplanted organ damage and therefore rejection. And so that is where we are commercializing first." "What's really interesting is that the innovations in this space are, okay, so let's say you've been on dialysis, that's a really tough life. You finally get your transplanted kidney, and now let's say your body is starting to reject it. You're one of those one in five who were a match, your kidney was a match for you, but then your immune system is attacking it anyway. That used to be almost a death sentence."  "Your options there were you're going to lose your kidney, you go back on dialysis, or you lose your life. But now there are therapies that are coming out to treat antibody-mediated rejection, or AMR, and our test is being used to monitor the efficacy of those therapies." #iMDx #MolecularDiagnostics #Molecular #Diagnostics #Healthcare #PrecisionMedicine #Genomics #Decentralized #LiquidBiopsy #DigitalPCR #Transplant #Localization #Labs #PointOfCareTesting #RapidCare #Democratization imdxinc.com Listen to the podcast here  

Andrea James, Chief Financial Officer at iMDx, is focused on expanding access to innovative molecular diagnostic testing staring with a test for monitoring transplanted organ health.  The test measures the donor-derived cell-free DNA which can indicate the need for drugs to target organ rejection before invasive procedures are required. The company is developing a kit-based version of the test that can be run by hospitals rather than relying on centralized labs, to increase access to this diagnostic and improve transplant outcomes. Andrea explains, "We changed our name on June 17th from OncoCyte, as you had just referenced, to Insight Molecular Diagnostics Inc. We're now going by iMDx, and our mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes." "We actually have three pieces of IP, intellectual property, and we are initially commercializing in transplant. So we measure a biomarker called donor-derived cell-free DNA, don't get too hung up on it. That's a lot of words. It basically looks for fragments of DNA in the blood, which can indicate transplanted organ damage and therefore rejection. And so that is where we are commercializing first." "What's really interesting is that the innovations in this space are, okay, so let's say you've been on dialysis, that's a really tough life. You finally get your transplanted kidney, and now let's say your body is starting to reject it. You're one of those one in five who were a match, your kidney was a match for you, but then your immune system is attacking it anyway. That used to be almost a death sentence."  "Your options there were you're going to lose your kidney, you go back on dialysis, or you lose your life. But now there are therapies that are coming out to treat antibody-mediated rejection, or AMR, and our test is being used to monitor the efficacy of those therapies." #iMDx #MolecularDiagnostics #Molecular #Diagnostics #Healthcare #PrecisionMedicine #Genomics #Decentralized #LiquidBiopsy #DigitalPCR #Transplant #Localization #Labs #PointOfCareTesting #RapidCare #Democratization imdxinc.com Download the transcript here

Some say two heads are better than one. Well we're testing that theory by checking out two films that have double the fun. First, things get all kinds of racist in THE THING WITH TWO HEADS. Then, how easy can one be corrupted by another in THE INCREDIBLE TWO HEADED TRANSPLANT.

Some say two heads are better than one. Well we're testing that theory by checking out two films that have double the fun. First, things get all kinds of racist in THE THING WITH TWO HEADS. Then, how easy can one be corrupted by another in THE INCREDIBLE TWO HEADED TRANSPLANT.

Why You Should Listen:  In this episode, you will learn about hair loss and some of the leading edge treatment options available today. About My Guest: My guest for this episode is Dr. Alan J. Bauman.  Alan J. Bauman, MD is an acclaimed board-certified hair restoration physician with nearly 30 years of experience in the medical field.  He is the founder and CEO of Bauman Medical, an international leading treatment center in the field of hair restoration.  Dr. Bauman received his Medical Doctor degree from New York Medical College in Valhalla, NY and underwent internship and residency training in surgery at Beth Israel Medical Center and Mt. Sinai Medical Center in Manhattan before dedicating his expertise to the specialized fields of hair transplant surgery and the treatment of hair loss.  With a particular focus on androgenetic alopecia or hereditary male or female pattern hair loss, Dr. Bauman has established himself as an authority in the industry.  He has treated over 34,000 patients, performed over 12,000 hair transplant surgeries, and administered over 12,000 PRP hair regrowth treatments.  He is a frequently invited faculty member and guest expert at numerous international scientific meetings and live surgery workshops and has been featured in hundreds of news stories in the media.  Dr. Bauman is one of approximately only 200 physicians worldwide to achieve the certification from the esteemed American Board of Hair Restoration Surgery (ABHRS).  He was voted “#1 Top Hair Restoration Surgeon” in North America by Aesthetic Everything for the 7th consecutive year, “Top Hair Restoration Surgeon of the Decade”, and received the 2022 “Lifetime Achievement Award in Hair Restoration”.  He was also recognized by Forbes as one of “10 CEOs Transforming Healthcare in America” and included in the ApeToGentlemen's list of the World's Best Hair Transplant Doctors for 4 years straight. Key Takeaways: What are the stages of hair loss? What are the different types of hair loss? What are some of the underlying causes of hair loss? What role do hormones play in hair loss? Can GLP-1s cause hair loss? Is hair loss genetic or epigenetic? What is the connection to thyroid function, Hashimoto's, and broader autoimmunity? What is the role of nutrient deficiencies in hair loss? What role do chronic Lyme, mold, or COVID play in hair loss? Do chronic scalp infections impact hair growth? Do certain medications cause hair loss? How important is supporting circulation to optimize hair growth? Do mitochondria play a role in hair growth? Are environmental toxicants a factor in hair loss? Does stress play a role in hair loss? What systemic or topical medications can be used to reduce hair loss and optimize hair growth? Do peptides have a place in supporting hair growth? What shampoos may be helpful for supporting hair growth? What is the role of PRP, stem cells, and exosomes in supporting hair growth? Does red light have a place in supporting hair growth? When might a transplant be the only option?  What supplements may support hair growth? Connect With My Guest:  BaumanMedical.com Related Resources: Bauman TURBO LaserCap Dr. Bauman offers a complimentary New Patient Evaluation ($500 value) with the purchase of a TURBO LaserCap. Interview Date: August 8, 2025 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode221. Additional Information: To learn more, visit https://BetterHealthGuy.com. Follow Me on Social Media: Facebook - https://facebook.com/betterhealthguy Instagram - https://instagram.com/betterhealthguy X - https://twitter.com/betterhealthguy TikTok - https://tiktok.com/@betterhealthguy Disclosure: BetterHealthGuy.com is an affiliate of Bauman Medical.  Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

Dosing ECP for lung transplant rejection by TRANSFUSION's Monthly Podcast

Twenty eight Irish athletes are taking part in the World Transplant Games, which begin in Germany tomorrow. More than two thousand people from fifty countries will compete at the sporting event, which organisers say is a celebration of a second chance of life.

A widening project on I-75 enters its next phase, alleged fraud in Kentucky's driver's licensing system has state lawmakers calling for an investigation, a Lexington couple is on a mission to raise awareness about organ donation, how leaders in Warren County are planning for major growth, and a program serving adults with autism that's also supporting Kentucky's workforce.

Originally released in Apr 24, 2017 with the title 'Getting Ahead in Life' Modern medicine seeks to find ways to ease the struggle for those affected by disease and disability. One of these that went from science fiction to actual scientific possibility is head transplantation, transplanting the head of one individual onto the body of another.  This remaster includes more research, better music and higher quality vocals.

There is one celebrity who had a hair transplant and Raven thinks it's time for him to get one too!

Broadcast from KSQD, Santa Cruz on 8-07-2025: Dr. Dawn opens with groundbreaking news about the first successful islet cell transplant for type 1 diabetes without immunosuppression. A 42-year-old man received gene-edited donor cells that were modified to avoid immune rejection by removing tissue compatibility markers and adding protective proteins. The transplanted cells in his forearm began producing insulin autonomously, reducing his A1C by 42% over 12 weeks. This breakthrough could lead to off-the-shelf diabetes treatments without the cancer and infection risks of immunosuppressive drugs. She critiques a case where a patient was prescribed an expensive new osteoporosis drug without trying conservative treatments first. Dr. Dawn explains how this monoclonal antibody works by blocking sclerostin, essentially cutting the brake lines on bone formation. While effective for severe osteoporosis, the drug increases heart attack and stroke risk by 15%. She advocates for trying lifestyle changes, exercise, and established treatments before resorting to newer, more dangerous medications with questionable risk-benefit ratios. A caller asks about a pustular rash on his upper body that his acupuncturist suggests might be related to COVID vaccination. Dr. Dawn addresses the distribution pattern of the rash, suggesting possible causes like hot tub folliculitis or topical allergies based on the location. She discusses how to evaluate rashes by their characteristics and distribution rather than jumping to vaccine-related conclusions. The caller inquires about vaccine development timelines and whether rushed approval during COVID might have missed serious side effects. Dr. Dawn explains that mRNA vaccine technology existed for 10 years before COVID and discusses her theory about vaccine side effects. She describes how spike proteins may temporarily deplete anti-inflammatory mechanisms, leading to flare-ups of existing conditions like eczema or arthritis, but emphasizes these effects are generally temporary and rebuilding occurs over time. Caller asks about RFK Jr.'s stance on vaccine research and the long-term implications of reducing vaccine development. Dr. Dawn provides a nuanced response about problems with the current vaccine system, including government-guaranteed markets that incentivize overproduction of vaccines. She discusses the evolution from essential vaccines for devastating diseases to newer vaccines for less critical conditions, explaining the economic forces that drive development and the resulting over-vaccination in healthy populations versus the need to protect vulnerable individuals. Dr. Dawn concludes with an innovative medical technology - a robot mattress designed to prevent pressure ulcers in immobilized patients. The mattress contains 1,260 independently controlled pistons that create undulating checkerboard patterns, alternating pressure points to stimulate blood flow. Research showed that brief high pressure followed by relief works better than constant low pressure, reducing pressure ulcer areas by 34 times compared to standard foam padding.

There is one celebrity who had a hair transplant and Raven thinks it's time for him to get one too! Beach Hot Takes! The beach is so relaxing until it isn't! Anna, Raven and Producer Julie share their hot takes about the beach, can you relate? Are you up to date on this week's biggest news story? Anna and Raven will get you caught up on the trending news including the passing of Brandon Blackstock, Kelly Clarkson's ex-husband! Raven went to see his doctor and he needs to change his diet; not great news! How would you prefer to receive bad news from your doctor? Raven saw someone successfully return a 7-year-old carpet and Anna can't believe this is something people do and wants to know what you saw someone try to return. KPOP Demon Hunters? What is it and why is it the only thing that your young child wants to watch? Anna and Raven ask the kids to explain! Anna and Raven are looking for any Middle School Students who would like to report the headline news on the show! Raven's niece reports the headlines! Anna says for all you do, and all you put up with this week, you've earned yourself a drink. What did you do to earn your Mommy Margarita? Jessica and Matthew's daughter was offered a “single” in her new college dorm. Her roommate decided to go elsewhere at the last minute. There will be no changes to the pricing given the last-minute nature. Mom says absolutely not, even though their daughter wants to have a room all to herself. Mom thinks that it's important to have someone live with you, helps you make friends and be more social. She's afraid she'll never leave her room and become a hermit. Dad says it would have been a dream to have a single as a freshman, no loud music, random people in your tight room, just let her take it! What do you think? Donald and Jessica have a chance to win $3900! All they have to do is answer more pop culture questions than Raven in Can't Beat Raven!

In this episode, we sit down with Dr. Jeff Auletta, MD, to explore the latest advancements in stem cell transplants and cellular therapies, including breakthroughs in CAR T-cell therapy, hematopoietic cell transplantation (HCT), and more. As the senior vice president of health equity at the National Marrow Donor Program (NMDP) and chief scientific officer of CIBMTR, Dr. Auletta is at the forefront of ensuring equal access to these life-saving treatments, while improving post-transplant outcomes for patients. Dr. Auletta shares his expertise on the emerging frontiers of cellular therapies and their transformative potential for those battling blood cancers and blood disorders. In this conversation, we dive into: ·       The science and benefits of blood stem cell transplantation. ·       Common blood-based diseases treated through stem cell therapies. ·       The role of bone marrow in the circulatory system and overall health. ·       The three main sources of hematopoietic stem cells (HSCs). Whether you're curious about stem cell transplants, the risks involved, or how to become a donor, this episode provides a wealth of information on the cutting-edge world of cellular therapy. For more updates on Dr. Auletta's work, follow him on X @JeffAuletta. Episode also available on Apple Podcasts: https://apple.co/38oMlMr

In this week's episode, we'll learn more about the effects of daratumumab maintenance on minimal residual disease in patients with newly diagnosed, transplant-eligible multiple myeloma; the role of neutrophils in the pathophysiology of myeloproliferative neoplasms; and a genome-wide association study that identified novel genetic loci associated with the risk of heavy menstrual bleeding.Featured ArticlesDaratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease resultsDefective neutrophil clearance in JAK2^V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24Genome-wide meta-analysis of heavy menstrual bleeding reveals 36 risk loci

On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Gaurav Sharma, PhD, MBA, from the University of Texas Southwestern Medical Center in Dallas. Dr. Sharma discusses his paper, “Metabolic and transcriptomic insights into temperature controlled hypothermic preservation of human donor hearts.” The discussion explores: How donor hearts not offered or declined for transplantation responded in hypothermic preservation versus conventional static cold storage Potentially beneficial genetic signatures yielded by TCHP versus cold storage The surprising response of energy stores in the hearts to the different storage environments How multi-omic approaches could be applied to other organs For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

Aussie DJ and producer Cyril opens up about his hair transplant in Turkiye.Subscribe on LiSTNR: https://play.listnr.com/podcast/fifi-fev-and-nickSee omnystudio.com/listener for privacy information.

Rich E Rich and Ricky's bet has come due :: Can the dollar reach 0? :: Update on Ian's appeal failing :: RussiaGate :: Trump paranoid that his name was planted on the Epstein List :: Turd calls to say he hates Ricky :: Conspiracy to get men attracted to Down Syndrome girls :: Sydney Sweeny Nazi propaganda? :: Need for donated organs, so should the definition of death be broadened? :: Transplant surgeons breaking the rules :: Stem cells and clones :: Immigration not in the constitutional purview :: RFK jr finds dozens of organ donors may not have been dead :: Wisconsin pizza shop accidentally doses their customers with THC :: 2025-08-03 Hosts: Bonnie, Rich E Rich, Angelo

Title: "The Gift of Life: A Conversation with Dr. Alex Ancheta, Transplant Surgeon"  

Rich E Rich and Ricky's bet has come due :: Can the dollar reach 0? :: Update on Ian's appeal failing :: RussiaGate :: Trump paranoid that his name was planted on the Epstein List :: Turd calls to say he hates Ricky :: Conspiracy to get men attracted to Down Syndrome girls :: Sydney Sweeny Nazi propaganda? :: Need for donated organs, so should the definition of death be broadened? :: Transplant surgeons breaking the rules :: Stem cells and clones :: Immigration not in the constitutional purview :: RFK jr finds dozens of organ donors may not have been dead :: Wisconsin pizza shop accidentally doses their customers with THC :: 2025-08-03 Hosts: Bonnie, Rich E Rich, Angelo

Welcome to Season 5, Episode 31! Our guest today is Daniel Tam-Claiborne, a writer, multimedia producer, and nonprofit director. His latest work is the novel Transplants released by Simon & Schuster. It's a coming of age story following two young women—Lin, who is Chinese and Liz, who is Chinese American. They're both navigating the journey to find their truest selves in a world that doesn't know where either of them belong. The novel is an exploration of race, love, power, and freedom that reveals how—in spite of our divided times—even our fiercest differences may bring us closer than we can imagine. Tam-Claiborne is also the author of the short story collection What Never Leaves, and his writing has appeared in a variety of publications and outlets including Michigan Quarterly Review, Catapult, Literary Hub, Off Assignment, The Rumpus, HuffPost, and elsewhere. Outside of writing, Daniel serves on the Board of Directors of Seattle City of Literature and on the Advisory Board of Off Assignment. He's a frequent speaker, moderator, and host. In our conversation, we discuss the process of writing a novel, inspiration for Transplants, feelings of belonging, the importance of COVID and lockdown as an element of Transplants, the diversity in the Asian American community, and so much more. Transplants is a well-written, moving book that we think shares several common themes that resonate with so many audiences. Tam-Claiborne doesn't shy away from deep issues that Asian Americans, Asians, and expats face as he explores belonging, identity, and more. You can see more of Daniel's work on his website Travel Breeds Content or his Instagram account @datclaiborne. If you like what we do, please share, follow, and like us in your podcast directory of choice or on Instagram @AAHistory101. For previous episodes and resources, please visit our site at https://asianamericanhistory101.libsyn.com or our links at http://castpie.com/AAHistory101. If you have any questions, comments or suggestions, email us at info@aahistory101.com.

Imagine you've been on the kidney transplant waitlist for years, hoping for a second chance at life. Then, one day, you find out that your estimated wait time was longer than it should have been—not because of your health, but because your kidney function was calculated using a race coefficient. That was the reality Black kidney patients faced. Now, that's changing. Dr. Vinay Nair, the Medical Director at North Shore University Hospital and Northwell Health, Morgan Reid, NKF's former Senior Transplant Policy and Strategy Director, and two kidney warriors Michele Bibby and Brittany Dickerson are here to break down the impact of removing race from eGFR and what that means for transplant patients   In today's episode we spoke to:  Dr. Vinay Nair, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell and the medical director of kidney transplantation for Northwell Health. Dr. Nair's clinical and research interests include novel immunosuppressive protocols, kidney paired exchange and infectious and malignant complications after transplantation. He serves as part of CERCA (coalition to end racism in clinical algorithms), the editorial board and reviewer of several nephrology and transplant journals, and has served in the UNOS kidney transplantation committee. Dr. Nair has published on various transplant related topics and co-authored book chapters on immunosuppression and post-transplant malignancy. He is an advocate for equality in medicine and has spoken at several community outreach events on the importance of chronic kidney disease recognition and kidney transplantation. Michele Bibby is President of MAB Consulting Services. Michele provides mental health education, advocacy, and policy analysis to public and private entities. Michele designs and delivers mental health workshops and training.  Michele delivers public speeches and presentations on mental health topics. Michele Bibby previously enjoyed a successful career in Human Resources Management in the Private and Public Sector.  Michele has a Professional in Human Resources (PHR) Certification. Michele is a Certified Peer Specialist and a Certified Mediator. Michele serves as Board Chair for Via Hope a Texas Mental Health Nonprofit.  Michele also serves on the National Kidney Foundation “Kidney Advocacy Committee” and the “Health Equity Sub Committee”. Michele holds a B.A. in Government from The University of Texas at Austin (1984).  Morgan Reid is the Regional Patient Advocacy Manager for Ardelyx, Inc.  Previously, she worked at the National Kidney Foundation as the Senior Director of Healthcare Policy and Strategy. She is a tireless patient advocate and also a kidney recipient herself. Brittany Dickerson- I am a dedicated mother, motivational speaker, and compassionate life coach living with Polycystic Kidney Disease (PKD). I use my kidney failure battle to educate and help others regarding kidney disease and transplantation. My personal journey has fueled my passion for helping others navigate life's challenges with courage and grace. Through partnership with the National Kidney Foundation, I have had the opportunity to mentor others and to be a guest for the National Kidney Foundation Podcast channel. My dedication to kidney awareness has led me to pursue becoming a National Kidney Foundation Advocate. I use my voice to spread my powerful message of perseverance and hope. My goal is to continue making an impact on individuals facing adversity, offering guidance, support, and being a shining example of strength in the face of hardship.    Additional Resources: Removing Race-Based eGFR   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Today, we sit down with Gregory S. Works

In this episode, we share why Matt's changed his mind about baby number three. We also talk about the Shettles Method, a theory on how to increase your chances of having a girl. Matt opens up about his upcoming hair transplant, we celebrate our sixth wedding anniversary and give some fun life updates. This episode is sponsored by Magic Spoon, Cash App & Hiya: Magic Spoon: Go to ⁠https://magicspoon.com/UNPLANNED⁠ and receive $5 off. Cash App: Download Cash App Today: https://capl.onelink.me/vFut/kssum24w #CashAppPod Hiya: Go to ⁠https://hiyahealth.com/UNPLANNED⁠ and receive 50% off your first order. Get your kids the full-body nourishment they need to grow into healthy adults. Learn more about your ad choices. Visit podcastchoices.com/adchoices